Fitzsimon_menu

Find out what's happening on campus and across the industry.

Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
News | May 24, 2023

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

Colorado Real Estate Journal features perspective from April Giles on what drives momentum for life sciences in our state.
News | Apr 25, 2023

Colorado Real Estate Journal features perspective from April Giles on what drives momentum for life sciences in our state.

The Benson Hotel and Faculty Club Slated to Open in April
News | Apr 25, 2023

The Benson Hotel and Faculty Club Slated to Open in April

PharmaLogic Announces Collaboration With Perspective Therapeutics
News | Apr 25, 2023

PharmaLogic Announces Collaboration With Perspective Therapeutics

Gates Grubstake Fund Awards Over $1.5 Million to Campus Researchers
News | Apr 25, 2023

Gates Grubstake Fund Awards Over $1.5 Million to Campus Researchers

Gates Institute Pushing CU Anschutz to the Forefront in Cell Therapy
News | Apr 25, 2023

Gates Institute Pushing CU Anschutz to the Forefront in Cell Therapy

Colorado BioScience Association Releases 2023 Peak Talent Report
News | Apr 25, 2023

Colorado BioScience Association Releases 2023 Peak Talent Report

Atara Biotherapeutics Named one of BioSpace's top Neurodegenerative Readouts of 2023
News | Apr 20, 2023

Atara Biotherapeutics Named one of BioSpace's top Neurodegenerative Readouts of 2023

Foresight Diagnostics' PhasED-Seq Liquid Biopsy Approach Successfully Detects ctDNA in Majority of Patients: Study Shows Promise in Solid Tumor Recurrence Test
News | Apr 20, 2023

Foresight Diagnostics' PhasED-Seq Liquid Biopsy Approach Successfully Detects ctDNA in Majority of Patients: Study Shows Promise in Solid Tumor Recurrence Test

OncoVerity, Inc. Announces Exclusive Worldwide Licensing Rights to Cusatuzumab and Appoints Max Colao as Chief Executive Officer
News | Mar 30, 2023

OncoVerity, Inc. Announces Exclusive Worldwide Licensing Rights to Cusatuzumab and Appoints Max Colao as Chief Executive Officer

Discoveries Meet Momentum: A Year in Review
News | Jan 26, 2023

Discoveries Meet Momentum: A Year in Review

Fitzsimons Innovation Community releases its Second Annual Innovation Report focused on the momentum our Community members build on our campus to take their discoveries and projects from idea to market.

Atara claims first world approval for off-the-shelf T-cell therapy
News | Jan 04, 2023

Atara claims first world approval for off-the-shelf T-cell therapy

The company’s off-the-shelf or ‘allogeneic’ therapy tabelecleucel – now given the Ebvallo trade name – has been approved by the European Commission as a second-line treatment for a rare and potentially deadly cancer that afflicts some organ or bone marrow transplant recipients.